BBVA USA Bancshares’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,000
Closed -$271K 509
2019
Q4
$271K Buy
+6,000
New +$251K 0.02% 464
2019
Q3
Sell
-7,626
Closed -$328K 391
2019
Q2
$328K Sell
7,626
-1
-0% -$38 0.02% 435
2019
Q1
$293K Buy
7,627
+1,530
+25% +$58.4K 0.02% 443
2018
Q4
$216K Buy
6,097
+38
+0.6% +$1.38K 0.02% 467
2018
Q3
$233K Sell
6,059
-115
-2% -$4.02K 0.01% 501
2018
Q2
$201K Sell
6,174
-9,161
-60% -$276K 0.01% 503
2018
Q1
$419K Sell
15,335
-2,965
-16% -$80.6K 0.03% 396
2017
Q4
$453K Sell
18,300
-2,005
-10% -$55.3K 0.03% 376
2017
Q3
$593K Sell
20,305
-5,536
-21% -$153K 0.04% 340
2017
Q2
$716K Sell
25,841
-17,175
-40% -$456K 0.05% 317
2017
Q1
$1.07M Sell
43,016
-31,542
-42% -$767K 0.07% 247
2016
Q4
$1.61M Sell
74,558
-38,085
-34% -$831K 0.11% 172
2016
Q3
$2.68M Sell
112,643
-60,871
-35% -$1.45M 0.19% 117
2016
Q2
$4.05M Buy
173,514
+38,914
+29% +$842K 0.3% 81
2016
Q1
$2.53M Buy
+134,600
New +$2.36M 0.19% 121

Other funds holding BSX

BBVA USA Bancshares's BSX Position: Q1 2020 in Review

BBVA USA Bancshares sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 6,000 shares — an estimated $271K sold.

BBVA USA Bancshares first reported a position in BSX in Q1 2016 and held it in 15 quarters. The position peaked at $4.05M in Q2 2016. 801 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • BBVA USA Bancshares reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • BBVA USA Bancshares sold 6,000 Boston Scientific shares in Q1 2020, an estimated $271K.
  • BBVA USA Bancshares first reported a position in Boston Scientific in Q1 2016 and held it in 15 quarters.
  • BBVA USA Bancshares's Boston Scientific position peaked at $4.05M in Q2 2016.
  • 801 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on BBVA USA Bancshares's 13F filing for Q1 2020, filed 27 Apr 2020.